Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial of gemtuzumab ozogamicin for adults with acute myeloid leukemia, including acute promyelocytic leukemia and various cytogenetic subtypes, has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | Status: WITHDRAWN